Neurim v Generics UK Limited (t/a Mylan) [2020] EWHC 1362 (Pat)

Neurim Pharmaceuticals (1991) Limited is the registered proprietor of EP(UK) 1,441,702 B1 (the Patent). Flynn Pharma Limited is registered as an exclusive licensee. The Patent claims prolonged release pharmaceutical formulations concerning the active ingredient melatonin to improve the restorative quality of sleep in a patient suffering from primary insomnia characterised by non-restorative sleep. Flynn distributes a pharmaceutical formulation claimed by the Patent under the brand name Circadin. Mylan propose imminently to release a “generic” rival to Circadin.

Neurim and Flynn sought a preliminary injunction to prevent Mylan’s launch. The application was heard by Marcus Smith J on 3 June 2020 remotely by video link. The Judge refused to order the injunction, deciding that damages caused by a wrongful failure to grant it would be an adequate remedy for Neurim and Flynn under Stage 2 of the American Cyanamid test. The Judge held that it was unnecessary for him to consider Stage 4 of that test (the Balance of Convenience) but would have invited further submissions (were he to have been minded to grant an interim injunction) in light of the request from the Secretary of State for Health (writing on behalf of the National Health Service) that an additional cross-undertaking be provided.

Mark Vanhegan QC and Adam Gamsa appeared for Mylan

[2020] EWHC 1362 (Pat)

Latest News

Anna Edwards-Stuart appointed King’s Counsel

Chambers is delighted to announce that Anna Edwards-Stuart has been appointed King’s Counsel in the 2023 competition, announced on 19th January 2024.

Miruna Bercariu joins 11 South Square

Chambers is delighted to announce Miruna Bercariu has accepted an offer of tenancy after a successful pupillage and will commence practice immediately....

Chambers UK Bar Awards 2023

Chambers is thrilled to announce we have won all three of the awards we were nominated for at the Chambers UK Bar Awards 2023. 11 South Square, IT/IP Set of the Year Brian Nicholson KC, IT/IP Silk of the Year Ka...

Edward Cronan joins 11 South Square

We are pleased to announce the arrival of a new member of chambers, Edward Cronan. Edward first came on to our radar at 11 South Square when he was a solicitor, and we watched his move to the bar in 2018 with interest. S...

Bio-science Law Review – University Inventions: When is a student a consumer?

University Inventions: When is a student a consumer? Oxford University Innovation Limited v Oxford Nanoimaging Limited [2022] EWHC 3200 (Pat) This article provides a case comment on the Judgment of Daniel Alexander KC...

Michael Silverleaf called to the Irish Bar

Chambers is pleased to announce that Michael Silverleaf has been called to the Irish Bar and has appeared in that role as part of a team representing Bristol-Myers Squibb in the Irish High Court before Barrett J. The tri...

Lionel Bently made Honorary King’s Counsel

Chambers is delighted to announce that Lionel Bently has been made an Honorary King's Counsel. Honorary KCs are awarded to those who have made a major contribution to the law of England and Wales, outside practice in...